4/3/2023 0 Comments Mono treatment![]() ![]() This is a multicenter comparative evaluation of commercially available serologic tests.ĭe Schryver A, Klein G, Hewetson J, et al.: Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA). This article reviews diagnostic methods, including complete protocols for serologic diagnostic tests.īruu AL, Hjetland R, Holter E, et al.: Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Washington, DC: American Society for Microbiology Press 2002:615–626. Edited by Rose NR, Hamilton RG, Detrick B. In Manual of Clinical Laboratory Immunology, edn 6. Heterophil antibody and viral-specific responses. Sumaya CV, Ench Y: Epstein-Barr virus infectious mononucleosis in children. Immunol Rev 2003, 192:212–224.įleisher G, Henle W, Henle G, et al.: Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. Latour S, Veillette A: Molecular and immunological basis of Xlinked lymphoproliferative disease. Miller G, Grogan E, Rowe D, et al.: Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J Oral Pathol Med 1989, 18:410–415.īarberà JA, Hayashi S, Hegele RG, Hogg JC: Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Reichart PA, Langford A, Gelderblom HR, et al.: Oral hairy leukoplakia: observations in 95 cases and review of the literature. Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T: Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA: Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. Patients with selected complications frequently benefit from short-term corticosteroid therapy. Antiviral therapy has a limited, short-term effect on oropharyngeal shedding but has proven ineffective for the clinical manifestations of infectious mononucleosis. The role of these tests for patients with uncomplicated infectious mononucleosis is limited, although these tests are being increasingly used to monitor the state and level of EBV replication for severe infections and among immunocompromised patients. Several newer molecular diagnostic tests have become available that facilitate accurate monitoring of infection. Enzyme-linked immunosorbent assays have replaced the traditional immunofluorescence assays for EBV-specific antibodies. The heterophile antibody test and EBV-specific antibody tests remain the principal means of diagnosis of initial infection in otherwise healthy patients. EBV is also causally linked with several human malignancies. Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and is associated with severe infections in immunocompromised patients. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |